Wonbiogen Co., Ltd. (KOSDAQ:307280)
South Korea · Delayed Price · Currency is KRW 7,220.00
-160.00 (-2.17%)
At close: Apr 24, 2026
Wonbiogen Market Cap
Wonbiogen has a market cap or net worth of 51.21 billion as of April 24, 2026. Its market cap has increased by 27.76% in one year.
Market Cap
51.21B
Enterprise Value
36.68B
Revenue
35.24B
Ranking
n/a
PE Ratio
7.74
Stock Price
7,220.00
Market Cap Chart
Since January 26, 2021, Wonbiogen's market cap has increased from 47.59B to 51.21B, an increase of 7.61%. That is a compound annual growth rate of 1.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 51.21B | 8.08% |
| Dec 30, 2025 | 47.38B | 16.35% |
| Dec 30, 2024 | 40.72B | -32.55% |
| Dec 28, 2023 | 60.37B | 3.39% |
| Dec 29, 2022 | 58.40B | -21.09% |
| Dec 30, 2021 | 74.00B | 55.49% |
| Jan 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DuChemBIO | 256.24B |
| CG MedTech | 209.10B |
| OSTEONIC | 135.41B |
| Sewoon Medical | 124.25B |
| JW Shinyak | 113.14B |
| SCL Science | 73.31B |
| KM Corporation | 45.50B |
| MEDYSSEY Co.,Ltd | 42.78B |